相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P. Tashkin et al.
LANCET RESPIRATORY MEDICINE (2016)
Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies
Elizabeth R. Volkmann et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
Interstitial lung disease in systemic sclerosis
Athol U. Wells
PRESSE MEDICALE (2014)
Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease
Aryeh Fischer et al.
JOURNAL OF RHEUMATOLOGY (2013)
Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies
Muriel Elhai et al.
RHEUMATOLOGY (2012)
Joint analysis of bivariate longitudinal ordinal outcomes and competing risks survival times with nonparametric distributions for random effects
Ning Li et al.
STATISTICS IN MEDICINE (2012)
Effect of mycophenolate sodium in scleroderma-related interstitial lung disease
Carmen Pilar Simeon-Aznar et al.
CLINICAL RHEUMATOLOGY (2011)
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
Anthony J. Tyndall et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Treatment of Scleroderma-Interstitial Lung Disease With Cyclophosphamide Is Associated With Less Progressive Fibrosis on Serial Thoracic High-Resolution CT Scan Than Placebo Findings From the Scleroderma Lung Study
Jonathan Goldin et al.
CHEST (2009)
Minimally important differences in the Mahler's Transition Dyspnoea Index in a large randomized controlled trial-results from the Scleroderma Lung Study
Dinesh Khanna et al.
RHEUMATOLOGY (2009)
A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
Chris T. Derk et al.
RHEUMATOLOGY (2009)
Classification of parenchymal abnormality in scleroderma lung using a novel approach to denoise images collected via a Multicenter study
Hyun J. Kim et al.
ACADEMIC RADIOLOGY (2008)
Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease
Anthony J. Gerbino et al.
CHEST (2008)
Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease
Ana C. Zamora et al.
RESPIRATORY MEDICINE (2008)
A joint model for longitudinal measurements and survival data in the presence of multiple failure types
Robert M. Elashoff et al.
BIOMETRICS (2008)
Effects of 1-year treatment with CycNophosphamilde on outcomes at 2 years in scleroderma lung disease
Donald P. Tashkin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Mycophenolate mofetil in diffuse cutaneous systemic sclerosis - a retrospective analysis
S. I. Nihtyanova et al.
RHEUMATOLOGY (2007)
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
Rachel K. Hoyles et al.
ARTHRITIS AND RHEUMATISM (2006)
Mycophenolate mofetil is safe, well tolerated, and preserves lung function, in patients with connective tissue disease-related interstitial lung disease
Jeffrey J. Swigris et al.
CHEST (2006)
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
分享论文
